Advances in biofeedback and neurofeedback studies on smoking
Smoking is a leading cause of morbidity and premature death constituting a global health challenge. Although, pharmacological and behavioral approaches comprise the mainstay of smoking cessation interventions, the efficacy and safety of pharmacotherapy is not demonstrated for some populations. Non-p...
Main Authors: | N. Pandria, A. Athanasiou, L. Konstantara, M. Karagianni, P.D. Bamidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158220302345 |
Similar Items
-
Does combined training of biofeedback and neurofeedback affect smoking status, behavior, and longitudinal brain plasticity?
by: Niki Pandria, et al.
Published: (2023-01-01) -
Corrigendum to “Advances in biofeedback and neurofeedback studies on smoking” [NeuroImage: Clinical 28 (2020) 102397]
by: N. Pandria, et al.
Published: (2021-01-01) -
Integrated use of biofeedback and neurofeedback techniques in treating pathological conditions and improving performance: a narrative review
by: Beatrice Tosti, et al.
Published: (2024-03-01) -
Diagnosing ADHD using QEEG and planning EEG-biofeedback (Neurofeedback) therapy – pilot studies
by: Danuta Bogumiła Ochojska, et al.
Published: (2021-02-01) -
Meditation and Neurofeedback
by: Tracy eBrandmeyer, et al.
Published: (2013-10-01)